Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Salgaller

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Expert Opinion on Investigational Drugs|February 24, 2001
American Association for Cancer Research: Clinical trials of immunotherapeutics and immunologic monitoring. April 1-5, 2000, San Francisco, CA, USAM L Salgaller
Idrugs : the Investigational Drugs Journal|August 5, 2005
AACR - 91st meeting. Dendritic cell vaccine strategiesM L Salgaller
Expert Opinion on Investigational Drugs|November 4, 2000
Prostate cancer immunotherapy at the dawn of the new millenniumM L Salgaller
Expert Opinion on Investigational Drugs|February 24, 2001
American Association for Cancer Research: dendritic cells: strategies and vaccines. April 1-5, 2000, San Francisco, CA, USAM L Salgaller
Current Opinion in Molecular Therapeutics|March 16, 2001
Immune monitoring of cancer patients undergoing experimental immunotherapyG Shankar, M L Salgaller
Expert Opinion on Investigational Drugs|November 4, 2000
Immunologic approaches to antigen discovery for cancer vaccinesL A Jones, M L Salgaller
Current Opinion in Molecular Therapeutics|March 16, 2001
Viral vectors for gene transfer into antigen presenting cellsS J Monahan, M L Salgaller
Journal of Biomedical Materials Research|January 1, 1985
Immunogenicity of glutaraldehyde-treated bovine pericardial tissue xenografts in rabbitsM L Salgaller, P K Bajpai
Expert Opinion on Investigational Drugs|July 5, 2005
Therapeutic potential of dendritic-based vaccinesL A Jones, M L Salgaller
Expert Opinion on Investigational Drugs|November 4, 2000
Progress in active-specific immunotherapy of brain malignanciesB A Tjoa, M L Salgaller
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|February 24, 2001
American Association for Cancer Research: Clinical trials of immunotherapeutics and immunologic monitoring. April 1-5, 2000, San Francisco, CA, USAM L Salgaller
Idrugs : the Investigational Drugs Journal|August 5, 2005
AACR - 91st meeting. Dendritic cell vaccine strategiesM L Salgaller
Expert Opinion on Investigational Drugs|November 4, 2000
Prostate cancer immunotherapy at the dawn of the new millenniumM L Salgaller
Expert Opinion on Investigational Drugs|February 24, 2001
American Association for Cancer Research: dendritic cells: strategies and vaccines. April 1-5, 2000, San Francisco, CA, USAM L Salgaller
Current Opinion in Molecular Therapeutics|March 16, 2001
Immune monitoring of cancer patients undergoing experimental immunotherapyG Shankar, M L Salgaller
Expert Opinion on Investigational Drugs|November 4, 2000
Immunologic approaches to antigen discovery for cancer vaccinesL A Jones, M L Salgaller
Current Opinion in Molecular Therapeutics|March 16, 2001
Viral vectors for gene transfer into antigen presenting cellsS J Monahan, M L Salgaller
Journal of Biomedical Materials Research|January 1, 1985
Immunogenicity of glutaraldehyde-treated bovine pericardial tissue xenografts in rabbitsM L Salgaller, P K Bajpai
Expert Opinion on Investigational Drugs|July 5, 2005
Therapeutic potential of dendritic-based vaccinesL A Jones, M L Salgaller
Expert Opinion on Investigational Drugs|November 4, 2000
Progress in active-specific immunotherapy of brain malignanciesB A Tjoa, M L Salgaller
Pageof 4